Glucose‐Responsive Insulin and Delivery Systems: Innovation and Translation
Year: 2019
Type: review
Abstract: Type 1 and advanced type 2 diabetes treatment involves daily injections or continuous infusion of exogenous insulin aimed at regulating blood glucose levels in the normoglycemic range. However, current options for insulin therapy are limited by the risk of hypoglycemia and are associated with suboptimal glycemic control outcomes. Therefore, a range of glucose-responsive components that can undergo changes in conformation or show alterations in intermolecular binding capability in response to glucose stimulation has been studied for ultimate integration into closed-loop insulin delivery or "smart insulin" systems. Here, an overview of the evolution and recent progress in the development of molecular approaches for glucose-responsive insulin delivery systems, a rapidly growing subfield of precision medicine, is presented. Three central glucose-responsive moieties, including glucose oxidase, phenylboronic acid, and glucose-binding molecules are examined in detail. Future opportunities and challenges regarding translation are also discussed.
Source: Advanced Materials
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Bio-Inspired Synthetic Pathway for Closed-Loop Delivery of Insulin and Glucagon, Characterizing Impulsivity as a Determinant of Weight and Glycemic Control in Youth with Type 1 Diabetes, G2148276352, G2322144016, G3376668938, G4339620272, North Carolina Translational and Clinical Science Institute (NC TraCS), G7042236906, G7681175737, Engineering Biomimetic Glucose-Responsive Vesicles for Self-Regulated Insulin Delivery, Towards Glucose Transporter-Mediated Glucose-Responsive Insulin Delivery with Fast Response
OpenAlex ID: W2969871554
